Engineers sharpen gene-editing tools to target cystic fibrosis

Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic “base pairs” to a new level of precision, opening the door to safer, more reliable therapies for a wide range of genetic diseases, and to potential treatments for some cystic fibrosis patients that may yield better outcomes than existing therapies.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup